These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1804040)

  • 1. Nitrogranulogen-dependent inhibition of antibody synthesis. I. In vitro studies in man.
    Wasik M; Stepień-Sopniewska B; Kozakiewicz A; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):117-20. PubMed ID: 1804040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
    Lagodziński Z; Górski A
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):121-5. PubMed ID: 1804041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogranulogen: a strong inhibitor of human lymphocyte proliferation.
    Wasik M; Górski A
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):49-54. PubMed ID: 2619509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice.
    Paczek L; Gaciong Z; Górski A; Lagodziński Z; Brzezny M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):415-9. PubMed ID: 2639638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin: an immunomodulator of antibody production in man.
    Górski A; Korczak-Kowalska G; Nowaczyk M; Gaciong Z; Skopińska-Rózewska E
    Immunology; 1982 Nov; 47(3):497-501. PubMed ID: 6215339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunobiological effects of nitrogranulogen. I. Summarizing the results of the immunological studies to date].
    Górski A; Wasik M; Nowaczyk M; Stepień-Sopniewska B
    Pol Arch Med Wewn; 1991 Aug; 86(2):65-7. PubMed ID: 1775392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.
    Stevenson HC; Fauci AS
    Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs inhibit class II antigen (HLA-D) synthesis by B and T lymphocytes.
    Nowaczyk M; Pluta A; Modlińska M; Bukowska J; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):415-9. PubMed ID: 2130806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
    Fidler JM; DeJoy SQ; Gibbons JJ
    J Immunol; 1986 Jul; 137(2):727-32. PubMed ID: 3487580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action.
    Rosenthal GJ; Weigand GW; Germolec DR; Blank JA; Luster MI
    J Immunol; 1988 Jul; 141(2):410-6. PubMed ID: 2968399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro.
    Wasik M; Rychlik G; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):259-65. PubMed ID: 2102658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lindane exposure on rainbow trout (Oncorhynchus mykiss) immunity. II. In vitro restoration of antibody-secreting cells and lymphocyte proliferation activity by nitrogranulogen after in vivo immunosuppression due to lindane.
    Siwicki AK; Dunier M
    Ecotoxicol Environ Saf; 1994 Apr; 27(3):316-23. PubMed ID: 7519550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the immunosuppressive properties of Sch 24937.
    Smith SR; Terminelli C; Epps S; Watnick A; Umland S
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):333-59. PubMed ID: 2963854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens.
    Hawrylowicz CM; Klaus GG
    Immunology; 1984 Feb; 51(2):327-32. PubMed ID: 6607211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interferon-alpha on immunoglobulin synthesis by human B cells.
    Peters M; Ambrus JL; Zheleznyak A; Walling D; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3153-7. PubMed ID: 3021846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of thymosin on human blood lymphocytes in vitro].
    Kosmiadi GA; Grigor'eva MP; Korotaev GK; Il'intseva IE; Grigor'ev MIu
    Vopr Onkol; 1979; 25(10):7-11. PubMed ID: 315663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
    Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.